Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2005 1
2006 1
2007 1
2008 1
2016 1
2017 2
2018 2
2019 2
2020 1
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The treatment of balanitis xerotica obliterans.
Depasquale I, Park AJ, Bracka A. Depasquale I, et al. BJU Int. 2000 Sep;86(4):459-65. doi: 10.1046/j.1464-410x.2000.00772.x. BJU Int. 2000. PMID: 10971272 Review. No abstract available.
Spontaneous bilateral breast haemorrhagic necrosis.
De Gabriele S, Macmillan MT, Nomikos A, Tahhan M, Masannat Y, Depasquale I, Miller I, Watson HG. De Gabriele S, et al. Among authors: depasquale i. Br J Haematol. 2017 Feb;176(4):666-668. doi: 10.1111/bjh.13980. Epub 2016 Feb 23. Br J Haematol. 2017. PMID: 26914631 Free article. No abstract available.
Microvessel density for melanoma prognosis.
Depasquale I, Thompson WD. Depasquale I, et al. Histopathology. 2005 Aug;47(2):186-94. doi: 10.1111/j.1365-2559.2005.02193.x. Histopathology. 2005. PMID: 16045780
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.
Khanolkar RC, Zhang C, Al-Fatyan F, Lawson L, Depasquale I, Meredith FM, Muller F, Nicolson M, Dahal LN, Abu-Eid R, Rajpara S, Barker RN, Ormerod AD, Ward FJ. Khanolkar RC, et al. Among authors: depasquale i. Front Immunol. 2022 Jan 5;12:763877. doi: 10.3389/fimmu.2021.763877. eCollection 2021. Front Immunol. 2022. PMID: 35069536 Free PMC article.
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.
Potter S, Trickey A, Rattay T, O'Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Potter S, et al. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. Br J Surg. 2020. PMID: 32073654
Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.
Murchie P, Masthoff J, Walter FM, Rahman K, Allan JL, Burrows N, Proby C, Lee AJ, Johnston M, Durrani A, Depasquale I, Brant B, Neilson A, Meredith F, Treweek S, Hall S, McDonald A. Murchie P, et al. Among authors: depasquale i. Trials. 2019 Jun 3;20(1):318. doi: 10.1186/s13063-019-3453-x. Trials. 2019. PMID: 31159849 Free PMC article.
14 results